Immediate Impact
30 standout
Citing Papers
Pathogenesis of allergic diseases and implications for therapeutic interventions
2023 Standout
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study
2023 Standout
Works of Arantza Vega being referenced
Venom Immunotherapy in Patients with Clonal Mast Cell Disorders: Efficacy, Safety, and Practical Considerations
2013
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Arantza Vega | 564 | 368 | 79 | 197 | 28 | 737 | |
| T. Hunziker | 257 | 313 | 17 | 222 | 41 | 846 | |
| Lichtenstein Lm | 350 | 230 | 40 | 50 | 27 | 652 | |
| Peter Kopač | 435 | 140 | 26 | 95 | 33 | 593 | |
| M.T. Guinnepain | 275 | 119 | 12 | 211 | 34 | 748 | |
| Lawrence M. Lichtenstein | 461 | 101 | 30 | 29 | 17 | 637 | |
| James M. Tracy | 624 | 87 | 164 | 48 | 23 | 810 | |
| Toshiharu Fujiyama | 143 | 288 | 7 | 106 | 42 | 706 | |
| Ulrich R. Müller | 489 | 59 | 134 | 39 | 15 | 578 | |
| G Sacerdoti | 170 | 221 | 2 | 146 | 30 | 669 | |
| Susanne Natter | 531 | 291 | 7 | 190 | 18 | 841 |
All Works
Login with ORCID to disown or claim papers
Loading papers...